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cultures of periprosthetic tissue samples were compared 
with the results of broad-range 16S rRNA gene real-time 
PCR (UMD-Universal Pathogen DNA Extraction and PCR 
Analysis, Molzym GmbH, Germany) and the multiplex-
PCR Unyvero ITI® cartridge system (U-ITI; Curetis AG, 
Germany). Conventional culture and broad-range 16S 
rRNA gene real-time PCR were performed on all samples. 
U-ITI was used in a subgroup of 28 cases including all cul-
ture-positive cases. The agreement of the results from the 
methods was assessed.
Results Of 54 cases, seven were culture-positive. Broad-
range 16S rRNA gene real-time PCR gave 6, U-ITI 3 con-
cordant positive results. Of the 47 culture-negative samples, 
46 were also negative by broad-range 16S rRNA gene real-
time PCR resulting in a 96 % (52/54) agreement between 
16S rRNA gene PCR and culture. Of the 21 culture-nega-
tive samples analysed with U-ITI, 20 gave negative results, 
including the single 16S rRNA gene PCR-positive/culture-
negative specimen. The rate of agreement between U-ITI 
and culture results was 82 % (23/28).
Conclusion This pilot study gave no indication of supe-
riority of the used NAATs over conventional culture meth-
ods for the microbiological diagnosis of PJI. Drawbacks 
are susceptibility to contamination in the case of 16S rRNA 
gene real-time PCR, labour-intensive DNA extraction and 
limited pathogen panel in the case of the multiplex car-
tridge PCR system. More prospective trials are needed to 
evaluate the diagnostic performance of NAATs and their 
impact on the clinical management of PJI.
Keywords Prosthetic joint infection · Orthopaedic 
surgical care · PCR · 16S rRNA gene real-time PCR
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Abstract 
Background Prosthetic joint infections (PJI) are associ-
ated with high morbidity and costs. Various efforts have 
been made to improve the diagnosis of PJI over the past 
years, but only few studies have assessed the diagnostic 
utility of nucleic acid amplification test (NAAT) techniques 
in this context. Here, we report our experience with a com-
mercial 16S rRNA gene PCR and an automated multiplex-
PCR cartridge system in identifying pathogens causing PJI.
Materials and methods A prospective single-centre study 
was performed including 54 patients with either septic or 
aseptic prosthetic joint replacement or surgical revision 
between February 2012 and April 2013. Conventional 
O. Hauschild and W. V. Kern are equally contributed to the 
manuscript.
Electronic supplementary material The online version of this 
article (doi:10.1007/s15010-015-0796-4) contains supplementary 
material, which is available to authorized users.
 * Johannes P. Borde 
 johannes.borde@web.de
1 Abteilung Infektiologie, Universitätsklinikum Freiburg, 
Hugstetterstr. 55, 79106 Freiburg, Germany
2 Institut für Medizinische Mikrobiologie und Hygiene, 
Universitätsklinikum Freiburg, Hermann-Herder-Straße 11, 
79104 Freiburg, Germany
3 Abteilung für Pädiatrische Infektiologie, Kinderklinik und 
Kinderpoliklinik im Dr. von Haunerschen Kinderspital, 
Ludwig Maximilians Universität, 80337 Munich, Germany
4 Department für Traumatologie, Sektion Endoprothetik, 
Universitätsklinikum Freiburg, Hugstetterstr. 55, 
79106 Freiburg, Germany
5 Curetis AG, Max-Eyth-Straße 42, 71088 Holzgerlingen, 
Germany
552 J. P. Borde et al.
1 3
NAAT  Nucleic acid amplification test
PJI  Prosthetic joint infection
U-ITI  Automated multiplex-PCR Unyvero i60 ITI® car-
tridge system
Introduction
Over the past decade there has been a significant increase 
in the number of artificial joint replacements worldwide 
and especially in Germany. Prosthetic joint infections (PJI) 
represent a serious complication in the era of artificial body 
implants. PJI is a condition with high morbidity and costly 
economic side effects for endoprosthetic departments [1, 
2]. The complex pathophysiology of PJI is closely related 
to the unique microbiological properties of biofilms, gener-
ated by microorganisms on artificial materials [3]. Biofilm-
forming bacteria often remain in a dormant state complicat-
ing conventional diagnostic and therapeutic approaches [4]. 
Recently updated international guidelines on the manage-
ment of PJI recommend the culture of 3–6 periprosthetic 
tissue samples as the diagnostic procedure of choice [5]. 
Various efforts have been made to improve the diagnostic 
tools for PJI over the past years. Culture samples obtained 
by sonication of removed artificial material were shown to 
be more sensitive than conventional tissue culture (78.5 vs. 
60.8 %.), especially in patients who were exposed to anti-
infective treatment 14 days before surgery (45 vs. 75 %)—
the overall specificities were above 98 % [6, 7]. Only few 
studies have assessed the diagnostic utility of nucleic acid 
amplification test (NAAT) techniques in this context. The 
reported findings for different PJI-associated materials indi-
cate a wide range of sensitivity (50–92 %) and specificity 
(65–94 %) [8–13]. Results from a recent study comparing 
16S rRNA gene PCR and consecutive sequencing of soni-
cation fluid with culture of synovial aspirates, tissue sam-
ples and sonication fluids reports that 16S rRNA gene PCR 
improved sensitivity [14]. An up-to-date large, prospec-
tive multicenter trial on 16S rRNA gene PCR applied to 
periprosthetic tissue samples showed a lack of sensitivity of 
this broad-spectrum molecular method (sensitivity 73.3 % 
and specificity 95.5 %) [8]. Almost no data are available 
on the role of multiplex-PCR assays for periprosthetic tis-
sue samples. Using multiplex-PCR of sonication fluid, sen-
sitivity (96 %) and specificity (100 %) for diagnosing PJI 
could be further improved and might help to differentiate 
between the clinical conditions of aseptic failure and PJI 
[15, 16]. However, the sophisticated infrastructure to obtain 
and process sonication fluids is not widely accessible, espe-
cially for endoprosthetic departments with external micro-
biological laboratories. To overcome these limitations, 
automated and easily operable multiplex-PCR systems are 
being developed, which provide rapid PCR results from 
periprosthetic tissue and bone samples regarding pathogen 
identification and genotypic resistance patterns. Here we 
report on our clinical experience comparing the automated 
multiplex-PCR Unyvero i60 ITI® cartridge (U-ITI) system 
with a 16S rRNA PCR assay and conventional culture in 
diagnosing PJI.
Materials and methods
Study design and ethical statement
This was a prospective study performed at Freiburg Univer-
sity Hospital, a large tertiary 1500-bed academic referral 
centre providing advanced specialized medical and surgi-
cal care including transplant centres and a level-1 trauma 
centre. The study protocol was approved by the ethics com-
mittee of the University of Freiburg (No. 60/12), and all 
patients gave written informed consent prior to any study-
related procedures.
The recruited patients were either patients with septic 
or aseptic prosthetic joint exchanges or revisions admitted 
between February 2012 and April 2013. The protocol spec-
ified that at least three periprosthetic tissue samples (bone 
tissue and soft tissue) be taken during the surgical proce-
dure for routine culture. Additional three periprosthetic tis-
sue samples were removed simultaneously and stored at 
−80 °C in DNA-, RNA- and ATP free tubes (2 mL, biopur, 
Eppendorf AG, Hamburg)—without using any cryo-pre-
servative agents. Synovial fluid was not processed. Frozen 
samples were thawed and split into portions for molecular 
assays. Clinical information was obtained from the medical 
records. A patient was regarded “clinically infected” based 
on the initial assessment (using medical history, clinical 
and radiological information) of the responsible orthopae-
dic surgeon prior to surgery.
Conventional culture microbiology
Tissue specimens were processed at the microbiology 
department on the basis of clinical routine protocols estab-
lished within the QM-system of the laboratory (DIN EN 
ISO 15189 and DIN EN ISO 17025 certified) in accordance 
with “Microbiology Procedures Quality Standards (MiQ)” 
issued by the German Society for Hygiene and Microbiol-
ogy. Briefly, tissue samples were minced and microscopi-
cally examined after Gram staining. Solid agar plates were 
inoculated for aerobic and anaerobic culture and brain heart 
infusion broth (Oxoid, Germany) as well as thioglycolate 
resazurin broth (Merck, Germany) for enrichment. All 
media were incubated for 14 days and inspected visually 
daily. Pathogen identification was done using MALDI-TOF 
MS (Bruker Daltonic GmbH, Germany). The diagnosis of 
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culture-positivity was based on the IDSA recommenda-
tions regarding the management of PJI [17]. In brief, two 
or more culture samples with the identical pathogen were 
considered as definitive positive. Growth of a highly patho-
genic organism, e.g., S. aureus in a single sample was also 
reported as definitive positive. Growth of an organism 
known as common contaminant in a single tissue sample 
was evaluated as negative.
Broad‑spectrum 16S rRNA gene real‑time PCR
DNA extraction, broad-spectrum 16S rRNA gene real-time 
PCR and sequence analysis were performed with UMD 
Universal kit according to the instructions of the manufac-
turer (Molzym GmbH, Germany). Strict precautions were 
taken as advised by the manufacturer to avoid DNA con-
tamination: only high-pure reagents were used. In brief a 
miliary portion of the tissue samples was processed. The 
manufacturer’s protocol includes the lysis of human cells 
and the removal of human DNA prior to pathogen lysis 
and DNA purification. For each set of samples subjected 
to DNA extraction a negative control (DNA-free water) 
was processed. The broad-spectrum real-time PCR using 
SYBR Green was carried out in a Light Cycler 2.0 (Roche, 
Germany). The kit provides primer targeting conserved 
regions of the 16S rRNA genes of bacteria and fungi, mas-
termix, DNA-free water for negative controls, DNA for 
positive controls and internal control DNA. For each PCR 
run, negative and positive controls were included. Inhibi-
tion of the PCR was excluded by adding internal controls 
to each sample extract. A sample was considered PCR posi-
tive if the melting curve analysis showed a peak within the 
expected Tm range [17]. Amplicons from positive PCR 
reactions were purified with GFX PCR DNA Purification 
kit. Sequencing reactions were performed using the Big-
Dye Terminator cycle sequencing kit DNA (version1.1; 
Applied Biosystem, Germany) according to the manufac-
turer’s instructions. The 16S rDNA PCR products were 
sequenced using sequencing primers (SeqGN16, SeqGP16) 
supplied in the UMD Universal kit and analysed with a 
3130 Genetic Analyzer (Applied Biosystem, Germany). 
Obtained sequences were compared with those in the Gen-
Bank database (http://www.ncbi.nlm.nih.gov/genbank/) 
using BLAST software (http://blast.ncbi.nlm.nih.gov). A 
sequence similarity level of ≥97 and ≥99 % was used as 
cutoff for genus and species identification, respectively. 
PCR-negative results were noted if melting curve analysis 
indicated the absence of bacterial DNA or sequencing anal-
ysis of poor mixed chromatograms did not generate suffi-
cient sequence homology. The Ripseq mixed programme 
(www.ripseq.com, provided by Isentio, Bergen, Norway) 
was not used in this study. The pathogen identified by 16S 
rRNA gene PCR was assessed as reliable when at least two 
of the three samples investigated indicated the same patho-
gen-related sequence.
Multiplex PCR cartridge system
The Unyvero Implant and Tissue Infection cartridge appli-
cation (U-ITI) is a semi-quantitative DNA test based on the 
parallel performance of eight multiplex PCR reactions and 
designed to detect up to 114 pathogen-associated nucleic 
acids and resistance markers in solid, fluid and highly vis-
cous samples. Tissue samples were processed by Curetis 
AG with the i60 Unyvero assay according to the manufac-
turer’s protocol. In brief, 27 mm3 of the tissue was trans-
ferred into a Unyvero sample tube. Sample lysis comprised 
a 30-min protocol including mechanical, thermal, chemical 
and enzymatic sample treatment. After sample lysis, the 
sample was further processed in the Unyvero i60 cartridge. 
The cartridge is pre-loaded with reagents for DNA purifica-
tion, PCR primers and probes for array hybridization. The 
U-ITI integrates and automates sample lysis, DNA purifica-
tion, multiplex nucleic acid amplification by end-point-PCR 
using fluorescence-labelled primers in eight independent 
PCR chambers with individual detection array and qualita-
tive amplicon detection by hybridization on a porous array 
membrane. PCR and array hybridization is performed with 
at least four probes per analyte. A series of images of the 
hybridization procedure over a specific temperature range 
is taken by a fluorescence camera. Results are derived from 
images processed by the Unyvero software, generating 
complete diagnostic information within 4.5 h. An internal 
control, a synthetic gene, without significant homology to 
known sequences, is co-processed in every PCR chamber 
to verify DNA purification, PCR and array hybridization. 
Analytical sensitivities regarding each microorganism and 
a complete list of all included pathogens and genetic resist-
ance markers are disclosed in the manufacturer’s manual. 
The result was reported as positive, when at least one of the 
analytes reached the threshold of positivity. The U-ITI was 
applied to 79 samples from 28 patient cases (23 cases with 
3 samples, 5 cases with 2 samples).
Categorization of results
PCR-based results were compared to conventional culture 
(CC) results by defining five categories of agreement [18]. 
The results of molecular diagnostics were assessed as true 
positive if conventional culture was concordant positive 
(NAAT+/CC+). Culture-positivity and a negative molec-
ular result were categorized as false negative (NAAT−/
CC+). If the PCR-based method and culture did not yield 
a pathogen, the result was classified as concordant nega-
tive (NAAT−/CC−). Cases with culture-negative speci-
mens but PCR-based positive results (NAAT+/CC−) were 
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considered as conclusive positive or false positive based on 
an additional case by case review of the available clinical 
information by infectious disease physicians.
Results
Samples and clinical information were obtained from 68 
patients of whom 14 were excluded because of insufficient 
clinical information or inappropriate pre-analytical tissue 
processing (Table 1). A total of 54 patients were included 
with either septic or aseptic prosthetic joint exchanges or 
revisions. Conventional culture detected the growth of pos-
sible pathogens in 16 patients. Considering the number of 
culture-positive samples per patient and the pathogenic-
ity of the microorganism, seven patients were classified 
as culture positive (Table 2). The remainder of nine cases 
was interpreted as contamination of the conventional cul-
ture on the basis of the above mentioned criteria and finally 
assessed culture-negative (Table 1, 3). Four patients met the 
criteria for culture positivity regarding coagulase-negative 
staphylococci: two patients with Staphylococcus lugdun-
ensis and one patient each with Staphylococcus capitis and 
Staphylococcus epidermidis, respectively. Staphylococcus 
aureus, Pseudomonas aeruginosa and Enterococcus faeca-
lis were identified by culture and considered true positive 
in one patient each.
Broad-spectrum 16S rRNA gene real-time PCR was car-
ried out for all samples of the 54 patients. Sequence analy-
sis was successful with species identification in 30 cases 
(Table 2). Twenty-nine microorganisms identified by 16S 
rRNA gene sequencing in 23 cases were considered con-
taminants according to the above mentioned criteria and 
finally assessed 16S rRNA gene real-time PCR-negative 
(Table 3). Contaminating DNA originated from Staphy-
lococcus spp. (n = 13), Staphylococcus haemolyticus 
(n = 2), Staphylococcus epidermidis (n = 1), Staphylo-
coccus hominis (n = 1), Pseudomonas pseudoalcaligenes 
(n = 6), Comamonas spp. (n = 5) and Pseudomonas spp. 
(n = 1). Only seven cases met the criteria of the identical 
pathogen-related sequences in at least two samples. All 
internal and positive PCR controls yielded the expected 
results.
In 96 % of all cases (52/54) there was agreement 
between the results from 16S rRNA gene real-time PCR 
and conventional culture (Table 3). Six of the seven cul-
ture-positive cases gave concordant positive results in the 
16S rRNA gene real-time PCR assay. Forty-six of 47 cul-
ture-negative samples were also estimated negative by 16S 
rRNA gene real-time PCR assay and categorized as con-
cordant negative. The one 16S rRNA gene real-time PCR-
positive/culture-negative sample (F-035) was interpreted as 
clinically true positive on the basis of prior culture results 
and antimicrobial treatment of the patient. In one culture-
positive case with growth of Staphylococcus capitis, 16S 
rRNA gene real-time PCR could not identify the pathogen 
and was classified as false-negative.
The Unyvero i60 ITI cartridge (U-ITI) was applied to 79 
samples of 28 patients (Table 3). In 23 cases three tissue 
samples and in five cases two samples were processed. In 
the five cases with only two tissue specimens investigated, 
the U-ITI result was concordant with culture findings. 
The overall degree of agreement between U-ITI and cul-
ture results in the 28 cases was 82 % (23/28). U-ITI iden-
tified 3 of 7 culture-positive cases revealing S. aureus, P. 
Table 1  Descriptive information and overview
Decriptive information
Total number of cases (n) 68
 Cases inclusion (n) 54




 Average age in years (time of inclusion) 69.08




 Average age in years (time of inclusion) 68.29
 Clinically infected (PJI) 3
  Conventional culture positive 3
  Conventional culture negative 0
 Clinically no PJI 16
  Conventional culture positive 1
  Conventional culture negative 15
 No clinical information on infection status at the time of inclu-
sion
2
  Conventional culture positive 0




 Average age (time of inclusion) 69.76
 Clinically infected (PJI) 7
  Conventional culture positive 1
  Conventional culture negative 6
 Clinically no PJI 19
  Conventional culture positive 1
  Conventional culture negative 18
 No clinical information on infection status at the time of inclu-
sion
7
  Conventional culture positive 1
  Conventional culture negative 6
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aeruginosa and E. faecalis. Results of the U-ITI molecular 
resistance typing function in comparison with conventional 
antimicrobial susceptibility testing are shown in Supple-
ment Table 1. Of the 21 culture-negative samples analysed 
with U-ITI, 20 gave concordant negative results, including 
the single 16S rRNA gene real-time PCR-positive/culture-
negative specimen (F-035). In this particular case S. aureus 
was detected by 16S rRNA gene real-time PCR. In one of 
21 culture-negative samples U-ITI identified Proteus spp.-
DNA (F-043). This finding was clinically assessed as false-
positive, and furthermore it was not confirmed by broad-
spectrum 16S rRNA gene real-time PCR.
Subgroup analysis
Patients were initially clinically categorized as “clinically 
infected” (n = 10), “no suspicion of infection” (n = 35) and 
“uncertain” (n = 9). Thirteen patients had been exposed to 
antimicrobial treatment within 14 days before sampling. 
Seven of these pretreated patients belonged to the subgroup 
labelled as “clinically infected”.
For “clinically infected” patients, culture confirmed the 
initial clinical suspicion only in 4 of 10 cases. 16S rRNA 
gene real-time PCR was concordant positive with culture 
findings in these 4 cases, and additionally identified S. 
aureus as likely causative agent in one culture-negative, 
antibiotic pretreated case (F-035). U-ITI was concordant 
positive in 3 of 4 culture-positive cases in this subgroup. 
U-ITI amplified Enterobacter cloacae DNA (198 units), 
just below the defined threshold of 250 units in one cul-
ture-negative, antibiotic pretreated patient in this subset. 
According to the manufacturer’s specifications this result 
was reported as negative. The clinical significance of this 
result remained unclear.
In three cases initially classified as “no suspicion of 
infection” (n = 2) or “uncertain” (n = 1) prosthetic joint 
infection was established by culture results. 16S rRNA 
gene real-time PCR confirmed the culture findings grow-
ing S. lugdunensis in two cases. U-ITI failed to verify these 
culture results because S. lugdunensis is not included in the 
detection panel. One case with positive cultures growing S. 
capitis could neither be verified by 16S rRNA gene real-
time PCR nor by U-ITI.
Discussion
The current gold standard in diagnosing PJI is the conven-
tional culture of periprosthetic tissue samples [19]. How-
ever, culture has limited sensitivity especially due to prior 
antimicrobial use, and its specificity is impaired by contam-
inating microorganisms of the skin which are often indis-
tinguishable from true pathogens in this setting. Several 
technical advances have broadened the diagnostic options 
in recent years [6, 14–16]. Here, we report on a pilot study 
comparing conventional tissue culture with two PCR-
based methods using prospectively collected tissue samples 
from patients with either septic or aseptic prosthetic joint 
replacements or revisions. Overall, we observed an agree-
ment of the U-ITI cartridge results with culture results in 
about 82 % of all cases. 16S rRNA gene real-time PCR 
results were in line with the conventional culture results 
in about 96 % of the studied patient cases. These find-
ings seem to be consistent with previously published data 
on NAAT techniques, indicating a relatively wide range 
of sensitivity and specificity [8–12]. NAATs may reason-
ably expand the diagnostic panel and contribute to a higher 
recovery rate especially after antimicrobial use.
However, each of the PCR-based methods has its spe-
cific drawbacks. Broad-range PCR is a very sensitive 
method and, thus, prone to false-positive results from con-
taminating DNA from different sources [20]. Attempts 
have been made to reduce the false-positive rates by intro-
ducing a detection threshold [21] but this may diminish the 
sensitivity of the test. In our study, 29 of 162 16S rRNA 
gene real-time PCR sequencing results, or 23 of 54 patient 
cases, were classified as contaminated especially by non-
fermenters such as Comamonas spp. or Pseudomonas spp. 
and coagulase-negative staphylococci of the skin. As it is 
not advised by the manufacturer we did not define a detec-
tion limit for 16S rRNA gene real-time PCR. To overcome 
the contamination problem and as done in literature before 
[8], an organism identified by 16S rRNA gene real-time 
PCR was reported as true pathogen when at least two of 
the three samples investigated showed the same pathogen-
related sequence. At this stage, the 16S rRNA gene real-
time PCR assay is labour-intensive regarding its DNA 
Table 3  Comparison of the different NAAT methods with conven-
tional culture (CC)





6/7 (85.7 %) 3/7 (42.9 %)
Concordant negative 
(NAAT−/CC−)










Overall agreement with 
CC
52/54 (96 %) 23/28 (82 %)
Total (n) n = 54 n = 28
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extraction procedure, which limits the introduction of this 
method into the clinical routine.
In contrast to the 16S rRNA gene real-time PCR assay, 
the U-ITI cartridge system is rapid and easy to operate. The 
test has an integrated thresholding algorithm. Amplification 
results reaching an arbitrary cut-off of 250 units are con-
sidered positive. Such a threshold can reduce false-positive 
results due to contamination and therefore might prevent 
unnecessary antimicrobial therapy. However, this approach 
poses the risk of false-negative results. In this pilot study 
we opted to report every single positive result as signifi-
cant as recommended by the manufacturer. In one culture-
negative, antibiotic pretreated and clinically infected case, 
the U-ITI cartridge amplified Enterobacter cloacae DNA 
at 198 units which is just below the defined threshold. The 
clinical significance of this result remained unclear. Com-
pared to broad-range PCR assays, the U-ITI is limited to a 
fixed panel of pathogens. The U-ITI cartridge includes 94 
primers (50 for bacterial or Candida species, and 42 resist-
ance markers) and even though the test covers important 
gram-positive and gram-negative pathogens, relevant spe-
cies such as Staphylococcus lugdunensis have not yet been 
included as a single primer in the latest version. In our 
study there were two culture-positive cases with Staphylo-
coccus lugdunensis, a clinically important pathogen caus-
ing various infections including joint and prosthetic joint 
infection [22–24]. U-ITI might benefit from the inclusion 
of additional organisms into the panel.
Our pilot study has several limitations. First, the over-
all number and the number of culture-positive patients 
included is relatively low; therefore, the agreement rate 
of 82 % is mainly based on concordant negative results. 
Larger studies with higher number of cases are certainly 
desirable to determine sensitivity and specificity, but dif-
ficult to conduct and, therefore, even smaller sample size 
studies may give important insights. Second, our “first-
experience” trial did not assess the influence of the NAAT 
results on the management of PJI. The only 4 U-ITI posi-
tive patient cases did not permit conclusions regarding the 
U-ITI molecular resistance typing function. We hypoth-
esize that the automated U-ITI cartridge may facilitate the 
management of PJI, especially in countries with a high 
prevalence of multi-drug resistant organisms and may be 
appropriate to detect polymicrobial PJIs. UMD-Universal 
assay and the U-ITI cartridge are new complementary tech-
nologies in the diagnostic repertoire for PJI.
In conclusion, this pilot study gave no indication of 
superiority of the used NAAT over conventional culture 
methods for the diagnosis of PJI. Prospective and con-
trolled trials will be necessary to evaluate the usefulness 
and the impact of NAATs on the clinical management of 
PJI.
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